Literature DB >> 15735133

CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma.

M Tiseo1, F Monetti, M Ferrarini, J Serrano, M Chiaramondia, A Ardizzoni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735133     DOI: 10.1200/JCO.2005.03.115

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Neuroendocrine carcinoma presenting as cardiac tamponade and dramatic response to steroids.

Authors:  Lakshmi Meenakshisundaram; Julia Smith; Beatrice Deshommes
Journal:  BMJ Case Rep       Date:  2011-03-03

Review 2.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

3.  Cyclosporine is a potential curative treatment option for advanced thymoma.

Authors:  Yusuke Isshiki; Hiroaki Tanaka; Yoshio Suzuki; Yukihiro Yoshida
Journal:  Exp Hematol Oncol       Date:  2017-05-03

4.  Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent.

Authors:  Guoyan Qi; Peng Liu; Huimin Dong; Shanshan Gu; Hongxia Yang; Yinping Xue
Journal:  Med Sci Monit       Date:  2017-03-09

Review 5.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.